BrightEdge - American Cancer Society
Company

BrightEdge - American Cancer Society

Venture Capital And Private Equity Principals Social Isolation and Other Critical Social Drivers of Health While Improving Collaboration Between Healthcare 35 employees
Employees
35
Contacts
2
Emails
2
Phones
1

BrightEdge - American Cancer Society Overview

Headquarters
Social Isolation and Other Critical Social Drivers of Health While Improving Collaboration Between Healthcare
Industry
Venture Capital And Private Equity Principals
Employees
35
Founded
2018
NAICS
Miscellaneous Intermediation

About BrightEdge - American Cancer Society

BrightEdge is the innovation, impact investment and venture capital arm of the American Cancer Society. Today, our donor-funded ACS Impact Venture Fund (AIVF) invests in for-profit, early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies to fuel and accelerate ACS’s mission of ending cancer as we know it, for everyone.

BrightEdge - American Cancer Society Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage
Phone contacts
1
25.0% coverage

BrightEdge - American Cancer Society Org Chart

Sample employees and titles
Name Title Contact
Carol Curtis, Ph.d. Entreprenuer - Scientist - Advisor
Email
Frank S. David Biotech Advisor, Author, & Teacher @ Pharmagellan, Tufts Biology
View
Jim Weiss Founder & Chairman, Real Chemistry; Executive Advisor, New Mountain Capital; Entrepreneur, Investor, Board Member, Advisor
View
Priya B. Executive - Entrepreneur - Start-up Advisor - Product Strategist - Consultant
Email Phone

Employees by Management Level

Individual contributor 3 profiles
Executive 1 profile

Compare Similar Companies to BrightEdge - American Cancer Society